Dopamine replacement therapy in Parkinson’s disease improves motor symptoms, however some patients suffer from motor and behavioural disturbances attributable to taking doses of medication well beyond the dose required to treat their motor disabilities. Dopamine dysregulation syndrome (DDS) can be regarded as a pattern of compulsive medication use, leading to disabling motor and behavioural features. DDS, probably attributed to pulsatile overstimulation of the limbic dopaminergic system, is characterised by severe dopamine addiction and behavioural disorders such as pathological gambling (PG), hypersexuality, punding and mood swings. PG is a form of impulse control disorder (ICD), consisting of persistent and maladaptive gambling of various types, which affects personal, family and occupational activity. The treatment of the syndrome is difficult, hence a strict adherence to antiparkinson medication should be encouraged for prevention.
Giovannoni G, O’sullivan JD, Turner K et al (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428PubMedCrossRefGoogle Scholar
Molina JA, Sáinz-Artiga MJ, Fraile A et al (2000) Pathologic gambling in Parkinson’s disease: a behavioural manifestation of pharmacologic treatment? Mov Disord 15:869–872PubMedCrossRefGoogle Scholar
Avanzi M, Baratti M, Cabrini S et al (2006) Prevalence of pathological gambling in patients with Parkinson’s disease. Mov Disord 21:2068–2072PubMedCrossRefGoogle Scholar
Voon V, Hassan K, Zurowski M et al (2006) Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66:1750–1752PubMedCrossRefGoogle Scholar
Grosset KA, Bone I, Grosset DG et al (2005) Suboptimal medication adherence in Parkinson’s disease. Mov Disord 20:1502–1507PubMedCrossRefGoogle Scholar
Grosset DG, Grosset KA (2006) Measuring therapy adherence in Parkinson’s disease: a comparison of methods. J Neurol Neurosurg Psychiatry 77:249–251PubMedCrossRefGoogle Scholar
Grosset DG, Grosset KA (2007) Effect of educational intervention on medication timing in Parkinson’s disease: a randomized controlled trial. BMC Neurol 7:20PubMedCrossRefGoogle Scholar